would it be fair to say, page-35

Jonty,
With all respect, it would not be leakage by a single employee, it would be the anticipation of a multi billion dollar industry expecting a sweeping innovation.

Such steps do not go unnoticed.

Follow other innovative technologies which do get a mention by the partner with upfront payments, license deals at early stages etc and watch what the price does in accordance to those developments.

We are long overdue for material news on all partnering fronts and that we up to date have not received milestone payments in any form is a telling story.

Why have there in 7 years of partnering efforts never any financial deals been struck, never any money been paid to protect our technologies?

GSK and other companies often early pay money to their partners to have them locked into financial pipelines, often only to be on the safe side as in to avoid leakage to the competition.



The only milestones we are about to reach are the performance shares issue milestones set out by management itself and that, most likely, be achieved through development of our own products on our own.

Not the outcome I invested for.